Abstract
Background: Chemotherapy is the primary treatment for acute lymphoblastic leukemia (ALL) but often leads to oral complications. This study investigated the impact of chemotherapy on oral health, caries risk, and the oral microbiome in pediatric patients. Methods: 39 children with ALL and 39 matched healthy controls were assessed for clinical oral health and caries risk (Cariogram). 16S rRNA sequencing was performed on a subset of 13 pairs. Results: Children with ALL showed higher rates of dental caries, gingivitis, and xerostomia, alongside a dysbiotic oral microbiome with reduced diversity. Conclusions: These findings highlight the need for personalized preventive dental management during cancer treatment.
Introduction
Acute Lymphoblastic Leukemia (ALL) is the most prevalent childhood cancer. While modern chemotherapy has pushed survival rates to nearly 90%, the treatment is systemic and harsh. Beyond immediate issues like mucositis, the long-term impact on "caries risk" (the likelihood of developing cavities) and the ecological health of the oral microbiome is a critical area of concern. This study provides a multi-dimensional analysis comparing clinical oral health, multi-factor risk profiles, and high-throughput genetic sequencing of oral bacteria between ALL patients and healthy controls.
Methods
This matched-case control study involved 39 children with ALL undergoing chemotherapy and 39 healthy counterparts (HC). Participants were matched based on age, gender, dentition stage, and socioeconomic status to ensure comparability and minimize confounding variables.
Clinical assessments included WHO criteria for decayed, missing, and filled teeth (dmft/DMFT), plaque indices, and salivary flow rates. Caries risk was modeled using the Cariogram tool, which integrates data on diet, bacteria, fluoride use, and salivary secretion. For microbiome analysis, 16S rRNA gene 454 pyrosequencing was performed on supragingival plaque samples from 13 randomly selected pairs.
Results
Clinical Oral Health and Caries Risk
The ALL group exhibited a significantly higher prevalence of dental caries (69.2% vs. 48.7%) and xerostomia (25.6% vs. 2.1%) compared to the healthy controls. The Cariogram analysis revealed a stark difference in the "chance of avoiding caries," with the ALL group median at 41.76% compared to 64.54% in the HC group. Additionally, ALL patients had a significantly lower stimulated salivary secretion rate (0.78 ml/min) compared to controls (1.01 ml/min).
Microbiome Dysbiosis
Sequencing data indicated that chemotherapy significantly alters the oral microbial landscape. The ALL group showed reduced alpha diversity, suggesting a less stable ecosystem. Taxonomic analysis revealed a shift toward Firmicutes ($p = 0.002$) and the enrichment of specific genera like Abiotrophia, while commensal genera such as Fusobacteria and Rothia were depleted.
Discussion
The findings suggest a "perfect storm" for oral disease in pediatric ALL patients. Chemotherapy-induced reduction in salivary flow and buffering capacity, combined with dietary changes and the difficulty of maintaining hygiene during treatment, shifts the oral environment toward high caries risk. The observed microbial dysbiosis—characterized by a loss of diversity and shifts in bacterial composition—further compromises oral health.
Conclusion
Pediatric patients with ALL undergoing chemotherapy face compromised oral health and significant microbiome shifts. Integrated care between oncologists and dentists is essential to implement personalized preventive strategies, mitigating long-term dental complications for childhood cancer survivors.
Summary updated